期刊文献+

过氧化物酶体增殖物激活受体-γmRNA在寻常性银屑病患者皮损中的表达

原文传递
导出
摘要 寻常性银屑病是一种以皮肤鳞屑性红斑为典型皮损的慢性复发性炎症性皮肤病,多项研究表明,其发病与炎症和角质形成细胞的异常凋亡相关,但其具体发病机制尚不清楚。
出处 《中华皮肤科杂志》 CAS CSCD 北大核心 2009年第12期854-855,共2页 Chinese Journal of Dermatology
  • 相关文献

参考文献5

  • 1Krueger JG. Bowcock A. Psoriasis pathophysiology: current concepts of pathogenesis. Ann Rheum Dis, 2005, 64 Suppl 2: ii30-36.
  • 2Pershadsingh HA. Peroxisome proliferator-activated receptorgamma: therapeutic target for diseases beyond diabetes: quo vadis? Expert Opin Investig Drugs, 2004, 13(3 ): 215-228.
  • 3Venkatraman MS, Chittiboyina A, Meingassner J, et al. Alpha- Lipoic acid-based PPARgamma agonists for treating inflammatory skin diseases. Arch Dermatol Res, 2004, 296( 3 ): 97-104.
  • 4Rivier M, Safonova I, Lebrun P, et al. Differential expression of peroxisome proliferator-activated receptor subtypes during the differentiation of human keratinocytes. J Invest Dermatol, 1998, 111(6): 1116-1121.
  • 5钟连生,魏志平,刘彦群,马道铭.过氧化物酶体增殖激活物受体γ在银屑病皮损中的表达[J].中国麻风皮肤病杂志,2007,23(12):1037-1039. 被引量:3

二级参考文献7

  • 1Kuenzli S, Saurat JH. Peroxisome proliferators activates receptors in cutaneous biology. Br J Dermatol 2003 ; 149: 229 - 236.
  • 2Issemann I, Green S. Activation of a member of the steroid hormonereceptor superfamily by peroxisome prolifemtors. Nature 1990; 347:645-650.
  • 3Lebwohl M, Ali S. Treatment of psoriasis. Part 1. Topical therapy and phototherapy. J Am Acad Dermatol 2001 ;45:487- 498.
  • 4Rivier M, Safonova I, Lebrun P, et al. Differential expression of peroxisome proliferator- activated receptor subtypes during the differentiation of human keratinocytes. J Invest Dermatol 1998; 111 (6) :1116- 1121.
  • 5Ellis CN, Varani J, Fisher GJ, et al. Troglitazone improves psoriasis and normalizes models of proliferative skin disease: hgands for peroxisome proliferator-activated receptor- gamma inhibit keratinocyte proliferation. Arch Dermatol 2000; 136:609 - 616.
  • 6Westergaard M, Henningsen J, Johansen C, et al. Expression and localization of peroxisome prolifemtor - activated receptors and nuclear factor kappaB in normal and lesional psoriatic skin. J Invest Dermatol 2003; 121(5) : 1104 - 1117.
  • 7Pershadsingh HA, Sproul JA, Benjamin E, et al. Treatment of psoriasis with troglitazone therapy. Arch Dermatol 1998; 134: 1304- 1305.

共引文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部